Korro Bio (KRRO)
NASDAQ:KRRO
Total Valuation
Korro Bio has a market cap or net worth of $201.92M. The enterprise value is $151.29M.
Market Cap$201.92M
Enterprise Value$151.29M
Share Statistics
Korro Bio has 14,422,571 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding14,422,571
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Korro Bio’s return on equity (ROE) is -2.28 and return on invested capital (ROIC) is -83.79%.
Return on Equity (ROE)-2.28
Return on Assets (ROA)-1.03
Return on Invested Capital (ROIC)-83.79%
Return on Capital Employed (ROCE)-0.86
Revenue Per Employee57.07K
Profits Per Employee-1.05M
Employee Count112
Asset Turnover0.06
Inventory Turnover0.00
Valuation Ratios
The current PE Ratio of Korro Bio is ―. Korro Bio’s PEG ratio is -0.02.
PE Ratio―
PS Ratio11.77
PB Ratio1.46
Price to Fair Value1.46
Price to FCF-0.95
Price to Operating Cash Flow-1.65
PEG Ratio-0.02
Income Statement
In the last 12 months, Korro Bio had revenue of 6.39M and earned -117.26M in profits. Earnings per share was -12.48.
Revenue6.39M
Gross Profit2.11M
Operating Income-87.34M
Pretax Income-116.62M
Net Income-117.26M
EBITDA-83.06M
Earnings Per Share (EPS)-12.48
Cash Flow
In the last 12 months, operating cash flow was -78.56M and capital expenditures -518.00K, giving a free cash flow of -79.08M billion.
Operating Cash Flow-78.56M
Free Cash Flow-79.08M
Free Cash Flow per Share-5.48
Dividends & Yields
Korro Bio pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta2.74
52-Week Price Change-6.23%
50-Day Moving Average11.68
200-Day Moving Average18.63
Relative Strength Index (RSI)65.94
Average Volume (3m)734.66K
Important Dates
Korro Bio upcoming earnings date is May 19, 2026, Before Open (Confirmed).
Last Earnings DateMar 12, 2026
Next Earnings DateMay 19, 2026
Ex-Dividend Date―
Financial Position
Korro Bio as a current ratio of 6.90, with Debt / Equity ratio of 84.54%
Current Ratio6.90
Quick Ratio6.90
Debt to Market Cap0.04
Net Debt to EBITDA-0.26
Interest Coverage Ratio0.00
Taxes
In the past 12 months, Korro Bio has paid 637.00K in taxes.
Income Tax637.00K
Effective Tax Rate>-0.01
Enterprise Valuation
Korro Bio EV to EBITDA ratio is -1.17, with an EV/FCF ratio of -1.23.
EV to Sales15.16
EV to EBITDA-1.17
EV to Free Cash Flow-1.23
EV to Operating Cash Flow-1.23
Balance Sheet
Korro Bio has $75.16M in cash and marketable securities with $43.49M in debt, giving a net cash position of $31.67M billion.
Cash & Marketable Securities$75.16M
Total Debt$43.49M
Net Cash$31.67M
Net Cash Per Share$2.20
Tangible Book Value Per Share$5.47
Margins
Gross margin is 89.85%, with operating margin of -1366.43%, and net profit margin of -1834.48%.
Gross Margin89.85%
Operating Margin-1366.43%
Pretax Margin-1824.52%
Net Profit Margin-1834.48%
EBITDA Margin-1299.47%
EBIT Margin-1366.43%
Analyst Forecast
The average price target for Korro Bio is $19.75, which is 11.43% higher than the current price. The consensus rating is Strong Buy
Price Target$19.75
Price Target Upside41.07% Upside
Analyst ConsensusStrong Buy
Analyst Count9
Revenue Growth Forecast―
EPS Growth Forecast21.61%